N-Acetylcysteine to Combat COVID-19: An Evidence Review
Zhongcheng Shi,1,2 Carlos A Puyo3 1Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA; 2Department of Pathology, Texas Children’s Hospital, Houston, TX, USA; 3Department of Anesthesia and Critical Care, Holy Family Hospital, Steward Health Care, Methuen, M...
Main Authors: | Shi Z, Puyo CA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/n-acetylcysteine-to-combat-covid-19-an-evidence-review-peer-reviewed-article-TCRM |
Similar Items
-
N-acetylcysteine as adjuvant therapy for hospitalized Covid-19 patients: A single-center prospective cohort study
by: Siamak Afaghi, et al.
Published: (2023-05-01) -
N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions
by: José Luis Izquierdo-Alonso, et al.
Published: (2022-12-01) -
Clinical efficacy of N-acetylcysteine for COVID-19: A systematic review and meta-analysis of randomized controlled trials
by: Ting-Hui Liu, et al.
Published: (2024-02-01) -
N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro
by: Javier Milara, et al.
Published: (2022-11-01) -
High-dose N-acetylcysteine therapy in the treatment of pneumonia
by: Dmytro Dmytriiev, et al.
Published: (2021-05-01)